Price $138.48 |
Market Cap
15.55B
|
Sector Health Care |
Div. Growth
7.40%
|
|
P/E
17.8
|
P/B
2.7
|
P/S
1.61
|
Dividend %
2.00%
|
|
P/CF
-
|
P/FCF
16.6
|
Op. Cash Flow
1.72M
|
FCF
8.4
|
|
Op. Margin
14.40%
|
Net Margin
9.50%
|
ROE
15.10%
|
ROI
11.70%
|
|
ROA
7.10%
|
EPS Growth
-49.40%
|
Current Ratio
1.2
|
Debt/Equity
67.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Vivos Inc (RDGL) | $0.06 | - | - | 24.9M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $0.97 | - | - | 5.1M | Strong Buy |
| IM Cannabis Corp (IMCC) | $0.70 | - | - | 13.9M | Strong Buy |
| Sesen Bio Inc (SESN) | $0.63 | - | - | 118.9M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.92 | - | - | 110.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
